E Archimbaud

7.6k total citations · 1 hit paper
124 papers, 5.1k citations indexed

About

E Archimbaud is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, E Archimbaud has authored 124 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Hematology, 37 papers in Oncology and 32 papers in Molecular Biology. Recurrent topics in E Archimbaud's work include Acute Myeloid Leukemia Research (72 papers), Hematopoietic Stem Cell Transplantation (22 papers) and Neutropenia and Cancer Infections (21 papers). E Archimbaud is often cited by papers focused on Acute Myeloid Leukemia Research (72 papers), Hematopoietic Stem Cell Transplantation (22 papers) and Neutropenia and Cancer Infections (21 papers). E Archimbaud collaborates with scholars based in France, United States and Belgium. E Archimbaud's co-authors include D Fière, Lydia Campos, Xavier Thomas, Denis Guyotat, Pierre Fenaux, C. Vasselon, Odile Sabido, N. Roubi, P. Oriol and JP Magaud and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

E Archimbaud

124 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy

1993 642 citations E Archimbaud et al. profile →

Peers

Countries citing papers authored by E Archimbaud

Since Specialization

Citations

This map shows the geographic impact of E Archimbaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Archimbaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Archimbaud more than expected).

Fields of papers citing papers by E Archimbaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Archimbaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Archimbaud. The network helps show where E Archimbaud may publish in the future.

Co-authorship network of co-authors of E Archimbaud

This figure shows the co-authorship network connecting the top 25 collaborators of E Archimbaud. A scholar is included among the top collaborators of E Archimbaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Archimbaud. E Archimbaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia 2000 ·Leukemia Research ·Xavier Thomas, Nathalie Cambier, A.-L. Taksin, Oumédaly Reman, Anne Vekhoff, Cécile Pautas, V. Leblond, (unknown), (unknown), E Archimbaud	7
2	Interdependence between Cytokines and Cell Adhesion Molecules to Induce Interleukin-6 Production by Stromal Cells in Myeloma 1998 ·Leukemia & lymphoma ·Xavier Thomas, Bruno Anglaret, Jean‐Pierre Magaud, Joshua Epstein, E Archimbaud	34
3	Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. 1998 ·Journal of Clinical Oncology ·Bob Löwenberg, Stefan Suciu, E Archimbaud, H. L. Haak, Pierre Stryckmans, (unknown), A. W. Dekker, Zwi Berneman, A. Thyss, J. van der Lelie, Pieter Sonneveld, Giuseppe Visani, Georges Fillet, M. Hayat, A Hagemeijer, G. Solbu, R Zittoun	218
4	Acute myelogenous leukaemia 1998 ·Critical Reviews in Oncology/Hematology ·Antonio Pinto, Gilbert B. Zulian, E Archimbaud	11
5	A Phase II Study of Interleukin-2 in 49 Patients with Relapsed or Refractory Acute Leukemia 1998 ·Leukemia & lymphoma ·(unknown), Norbert Vey, Patrice Viens, Anne-Marie Stoppa, E Archimbaud, Michel Attal, D Baume, Réda Bouabdallah, (unknown), Joël Fleury, Mauricette Michallet, Daniel Olive, Josy Reiffers, D Sainty, Antonio Tabilio, Pierre Tiberghien, Maud Brandely, Thierry Hercend, Didier Blaise	45
6	Differential adhesiveness between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression 1998 ·Leukemia Research ·Xavier Thomas, Bruno Anglaret, (unknown), (unknown), Jean‐Pierre Magaud, E Archimbaud	13
7	Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias 1997 ·Leukemia ·Sandrine Hayette, Xavier Thomas, Y. Bertrand, Isabelle Tigaud, Mary Callanan, Anne Thiébaut, C Charrin, E Archimbaud, J.P. Magaud, Ruth Rimokh	22
8	Granulocyte colony‐stimulating factor given in addition to interferon‐α to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia 1997 ·British Journal of Haematology ·E Archimbaud, Mauricette Michallet, I Philip, C Charrin, Gilles Clapisson, Amine Belhabri, François Guilhot, P Stryckmans, P Adeleine, D Fière	14
9	Timed sequential chemotherapy for advanced acute myeloid leukemia 1996 ·PubMed ·E Archimbaud, V. Leblond, Pierre Fenaux, Hervé Dombret, C. Cordonnier, François Dreyfus, Pascale Cony‐Makhoul, Hervé Tilly, Xavier Troussard, G Auzanneau, Xavier Thomas, Martine Ffrench, J. P. Marie	13
10	Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle. 1995 ·PubMed ·Arnaud Pigneux, A Devergié, (unknown), (unknown), E Archimbaud, J Cahn, (unknown), Marie‐Cécile Michallet, (unknown), François Guilhot	9
11	Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients 1995 ·European Respiratory Journal ·F. Philit, T Wiesendanger, E Archimbaud, (unknown), J Brune, (unknown)	98
12	Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial. 1995 ·Journal of Clinical Oncology ·E Archimbaud, Xavier Thomas, V. Leblond, M Michallet, Pierre Fenaux, Catherine Cordonnier, François Dreyfus, Xavier Troussard, J Jaubert, Philippe Travade	85
13	Place de la double induction dans le traitement des leucémies aiguës myéloblastiques de l'adulte : résultats intermédiaires du protocole LAM90 1994 ·Sylvie Castaigné, E Archimbaud, Pierre Fenaux, Dominique Bordessoule, Hervé Tilly, Marc A. Simon, Brigitte Dupriez, G Auzanneau, (unknown), G. Tertian, (unknown), M Renoux, (unknown)	2
14	Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission 1992 ·Annals of Hematology ·E Archimbaud, Bruno Anglaret, Xavier Thomas, J Jaubert, Catherine Sebban, Denis Guyotat, D Fière	6
15	Association of t(15;17) and t(8;21) in the initial phase of an acute promyelocytic leukemia 1992 ·Cancer Genetics and Cytogenetics ·C Charrin, (unknown), (unknown), Yves Devaux, E Archimbaud, (unknown), D Fière, D Germain	12
16	Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance 1991 ·British Journal of Haematology ·E Archimbaud, (unknown), (unknown)	43
17	Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy 1991 ·Cancer Chemotherapy and Pharmacology ·Gilles Salles, E Archimbaud, Xavier Thomas, D Fière	4
18	Correlations between cytogenetics and morphology in myelodysplastic syndromes 1990 ·Annals of Hematology ·(unknown), C Charrin, E Archimbaud, (unknown), (unknown), Pascale Felman, D Fière, D Germain	16
19	Acute leukaemia with t(4;11) in patients previously exposed to carcinogens 1988 ·British Journal of Haematology ·E Archimbaud, C Charrin, Denis Guyotat, (unknown), O Gentilhomme, (unknown)	23
20	Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia following Radiotherapy for Carcinoma of the Cervix 1987 ·Acta Haematologica ·E Archimbaud, C Charrin, Martine Ffrench, D Fière, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact